Interview - Inkompletter Querschnitt / Spinal Cord Injury
Interview mit dem Patienten vom Januar 2014 zu folgendem Video:http://youtu.be/xcoLm1pomhs Interview with the patience from January 2014 of the following vid...

By: Medi(c)al Thinking

Read more:
Interview - Inkompletter Querschnitt / Spinal Cord Injury - Video

Recommendation and review posted by sam

Lab Grown Vaginas Have Helped Four Women Live Normal Lives
Lab grown vaginas are helping four females live normal lives. Lab-grown vaginas are helping four females live normal lives. The organs were made by using the...

By: GeoBeats News

Go here to see the original:
Lab Grown Vaginas Have Helped Four Women Live Normal Lives - Video

Recommendation and review posted by sam

Lumbar Disc Pain 10 months after stem cell treatment by Dr Harry Adelson
Bill discusses his outcome 10 months after having his L4/5, L5/S1 discs injected with bone marrow stem cells by Dr Harry Adelson http://www.docereclinics.com.

By: Harry Adelson, N.D.

See the original post here:
Lumbar Disc Pain 10 months after stem cell treatment by Dr Harry Adelson - Video

Recommendation and review posted by Bethany Smith

By Estel Grace Masangkay

Bone marrow stem cells may help in stroke recovery, according to a team of researchers from the University of California, Irvines Sue and Bill Gross Stem Cell Research Center.

Neurologist Dr. Steven Cramer and biomedical engineer Weian Zhao together analyzed 46 studies evaluating the use of a type of multipotent adult stem cells mostly processed from the bone marrow called mesenchymal stromal cells (MSC) in animal models of stroke. Results showed that MSCs were superior to control therapy in 44 out of the 46 studies.

Dr. Cramer said Stroke remains a major cause of disability, and we are encouraged that the preclinical evidence shows [MSCs] efficacy with ischemic stroke. MSCs are of particular interest because they come from bone marrow, which is readily available, and are relatively easy to culture. In addition, they already have demonstrated value when used to treat other human diseases.

The MSCs effect on functional recovery was shown to be robust regardless of other factors such as dosage, time of administration relative to the stroke onset, or administration method. An earlier report focusing on MSC mechanisms of action explained how the cells were attracted to the injury sites and began releasing a wide range of molecules in response to signals emitted by the damaged areas. The molecules in turn stimulate several activities including blood vessel creation for enhanced circulation, protection of vulnerable cells, brain cell growth, and others. The MSCs also fostered an environment conducive to brain repair.

We conclude that MSCs have consistently improved multiple outcome measures, with very large effect sizes, in a high number of animal studies and, therefore, that these findings should be the foundation of further studies on the use of MSCs in the treatment of ischemic stroke in humans, said Dr. Cramer.

The UCI teams analysis appeared in the April 8 issue of Neurology.

See the original post:
UCI Team Discovers Bone Marrow Stem Cells' Potential In Stroke Recovery

Recommendation and review posted by Bethany Smith

Beverly Hills, CA (PRWEB) April 14, 2014

Top Los Angeles and Beverly Hills orthopedic surgeon, Dr. Raj, is now working with R3 Stem Cell at his Beverly Hills Orthopedic Institute to offer comprehensive regenerative medicine treatment. The stem cell procedures for shoulder, knee, and hip conditions typically work great for degenerative arthritis, tendonitis, and ligament injuries. For more information and scheduling with the top stem cell clinic in LA and Beverly Hills, call (310) 438-5343.

Dr. Raj treats athletes, celebrities, executives, grandparents, and everything in between. Oftentimes, the stem cell procedures are able to help athletes heal tendon and ligament injuries quickly, without surgery and get back to competition quickly. In addition, the stem cell procedures work well the majority of the time for degenerative arthritis of the hip, knee, and shoulder.

The stem cell material is either bone marrow derived from the patient or comes from amniotic fluid. The bone marrow derived stem cell injections are performed as an outpatient procedure. The bone marrow is harvested from the patient, immediately processed, and then injected into the problem area. The processing concentrates the stem cells and growth factors to increase the potential for repair and regeneration.

The amniotic fluid derived stem cells have been used tens of thousands of times around the world with no adverse events being reported, with the fluid being processed at an FDA regulated lab. The fluid contains stem cells, hyaluronic acid and growth factors to help repair damaged cartilage and injured tendons and ligaments. This can help patients avoid surgery for rotator cuff tendonitis and tears, elbow tendonitis, achilles tears, knee injuries and joint arthritis.

Dr. Raj is Double Board Certified and sees patients from the greater Los Angeles and Beverly Hills area. Numerous times, he has been named one of Los Angeles top orthopedic doctors, while also acting as an ABC News Medical Correspondent.

To schedule appointments for regenerative medicine stem cell procedures in Los Angeles for arthritis, tendon, or ligament injuries in Los Angeles, call Beverly Hills Orthopedic Institute at (310) 438-5343.

See the article here:
Beverly Hills Orthopedic Institute Now Working With R3 Stem Cell to Offer Bone Marrow and Amniotic Stem Cell ...

Recommendation and review posted by Bethany Smith

Scientists have used steroids to enhance the performance of stem cells (Photo: Shutterstock)

Stem cells are highly promising for the treatment of everything from HIV to leukemia to baldness. In many cases, however, a great number of them must be used in order have a noticeable effect, which makes treatments impractical or expensive. Now, scientists at Harvard-affiliated Brigham and Women's Hospital have found that a smaller number of stem cells can still get the job done, if they're first hopped up on steroids.

The research was conducted by Doctors Jeffrey Karp and James Ankrum, the former of whom has also helped bring us painless medical tape for newborns, worm-inspired skin grafts, porcupine quill-inspired surgical patches, and superglue for holes in the heart.

The scientists started with ordinary mesenchymal stem cells, and treated them with glucocorticoid steroids. This caused the cells to produce an increased amount of indoleamine-2,3-dioxygenase (IDO), which is an anti-inflammatory agent. Since it was noted that the cells' IDO expression was highest when they were actually being exposed to the steroids, the scientists added steroid-containing microparticles to the cells, so that they could have access to the drugs at all times.

When the 'roided-up stem cells were then introduced to inflamed immune cells, they were found to reduce inflammation twice as effectively as unmodified mesenchymal stem cells.

"Our approach enables fine tuning of cell potency and control following transplantation, which could lead to more successful cell-based therapies," said Ankrum.

A paper on the research was recently published in the journal Scientific Reports.

Source: Brigham and Women's Hospital

Just enter your friends and your email address into the form below

For multiple addresses, separate each with a comma

See the rest here:
Scientists give stem cells a performance boost ... by putting them on steroids

Recommendation and review posted by Bethany Smith

The first volunteers are expected to be treated by late 2016. If successful, the trial could pave the way to the wide-scale use of artificial blood derived from stem cells.

Blood cells freshly made in the laboratory are likely to have a longer life span than those taken from donors, which typically last no more than 120 days.

Loading article content

They would also be free from infectious agents such as viruses or the rogue prion proteins that cause Creuzfeldt-Jakob Disease (CJD).

Professor Marc Turner, medical director at the Scottish National Blood Transfusion Service (SNBTS), who is leading the 5 million project at the University of Edinburgh, said: "Producing a cellular therapy which is of the scale, quality and safety required for human clinical trials is a very significant challenge.

"But if we can achieve success with this first-in-man clinical study it will be an important step forward to enable populations all over the world to benefit from blood transfusions.

"These developments will also provide information of value to other researchers working on the development of cellular therapies."

The pilot study will involve no more than about three patients, who may be healthy volunteers or individuals suffering from a red blood cell disorder such as thalassaemia.

They will receive a small, five millilitre dose of laboratory-made blood to see how it behaves and survives in their bodies.

The blood cells will be created from ordinary donated skin cells called fibroblasts which are genetically reprogrammed into a stem cell-like state.

Go here to read the rest:
In the blood: Scottish scientists pioneer lab-grown cells

Recommendation and review posted by Bethany Smith

14/04/2014 - 13:40:33Back to World Home

Red blood cells grown in a laboratory are to be tested in patients for the first time by pioneering scientists.

The first volunteers are expected to be treated by late 2016. If successful, the trial could pave the way to the wide-scale use of artificial blood derived from stem cells.

Blood cells freshly made in the laboratory are likely to have a longer life span than those taken from donors, which typically last no more than 120 days.

They would also be free from infectious agents such as viruses or the rogue prion proteins that cause Creuzfeldt-Jakob Disease (CJD).

Professor Marc Turner, medical director at the Scottish National Blood Transfusion Service (SNBTS), who is leading the 5m project at the University of Edinburgh, said: Producing a cellular therapy which is of the scale, quality and safety required for human clinical trials is a very significant challenge. But if we can achieve success with this first-in-man clinical study it will be an important step forward to enable populations all over the world to benefit from blood transfusions.

These developments will also provide information of value to other researchers working on the development of cellular therapies.

The pilot study will involve no more than about three patients, who may be healthy volunteers or individuals suffering from a red blood cell disorder such as thalassaemia.

They will receive a small, five millilitre dose of laboratory-made blood to see how it behaves and survives in their bodies.

The blood cells will be created from ordinary donated skin cells called fibroblasts which are genetically reprogrammed into a stem cell-like state.

Read the original post:
Scientists to test artificial blood in humans

Recommendation and review posted by Bethany Smith

Sam Harrell #39;s Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis
Sam Harrell sent us this homemade video documenting his progress from 2010 until now (2014). Sam was coaching football at Ennis high school in Texas when MS ...

By: http://www.cellmedicine.com

The rest is here:
Sam Harrell's Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis - Video

Recommendation and review posted by Bethany Smith

Trinity final
At the Trinity Stem Cell Institute our medical team is among the most renowned in the world for their research and development of stem cell therapy for back ...

By: SMU Productions - Tampa Video Production

Read the original post:
Trinity final - Video

Recommendation and review posted by Bethany Smith

Miracele: Cell therapy by Mr. Cremmer
Mr. Clause Peter Cremmer CEO Founder or Edith Liebergeld Institute Mr. Cremer has an impressive array of inventions accredited to his name: 1999 -- Inventi...

By: Edith Liebergeld Institute

See the article here:
Miracele: Cell therapy by Mr. Cremmer - Video

Recommendation and review posted by Bethany Smith

Genetic Engineering and Selective Human Breeding
Should people be genetically engineering future changes in the human being? Probably not. But things like disease make it probably that humans will go down t...

By: Chris Freely

Go here to see the original:
Genetic Engineering and Selective Human Breeding - Video

Recommendation and review posted by Bethany Smith

Health risks, environmental damage and placards featuring corn cobs grimacing menacingly: the discussion about genetic engineering is ridden above all with anxieties. In a poll from environmental organization Greenpeace, the majority of German consumers strongly opposed the cultivation of the genetically modified (GM) corn variety 1507. This maize has been approved to be grown Europe-wide. DW gets to the bottom of the possible anxieties which regularly arise when it comes to this controversial crop.

No, it doesn't. One of the biggest concerns about the introduction of genetically modified corn is that consuming it could cause illness. But agricultural scientist Friedhelm Taube asserts that, to his knowledge "there are no scientific studies which have documented a danger to health." Furthermore, the vast majority of the corn under the German Farmers' Association ("Deutscher Bauernverband") would be produced as feed for dairy cows; the remainder would be used for the generation of energy in biogas plants. Therefore, the corn cultivated on a large-scale would not end up on the plates of consumers.

What about the cows' milk, though? The TUM Technical University in Munich ("Technische Universitt Mnchen") proved in 2008 that the genetically modified material in corn could be excluded from being passed on to consumers through milk. In a two-year study, cattle were fed with the genetically modified maize MON810, which like the currently-discussed GM corn variety 1507 has the gene of the naturally occurring bacteria bacillus thuringensis (Bt) introduced into its genetic makeup. The researchers detected neither illness in the cows, nor could they find traces of the genetically-modified material from the corn in the cows' milk.

Yes, it could be dangerous for vermin and other animals. The European Food Safety Authority (EFSA) examined the maize variety 1507 amongst others to see whether the protection from insects, for which it had been genetically modified, also endangered other animals apart from those which posed a danger to corn. The EU body based its statement on expert advice received from member states, for example the German Federal Office of Consumer Protection and Food Safety (BVL). According to that, the pollen of the maize had the highest concentrations of the self-produced insecticide. This successfully killed the damaging European corn borer, but also a related butterfly, the wax moth, which poses no threat to the maize. Greenpeace accused the EFSA of not adequately investigating the negative consequences of the Bt-protein on other types of insects.

For bees, researchers currently see no threat from the GM maize. Animal ecologists from the University of Wrzburg have probed the possible effects of Bt-maize pollen on honeybees and their larvae. They could not determine any negative consequences. However, this pollen can end up in the honey which the bees produce. Honey which has been gathered from the flowers of genetically modified plants is no longer allowed to be marketed as organic.

There's no definite answer yet. Corn is a cultivated plant and grows mainly in sunny and warm regions of the world. It originated from Mexico. In Germany, maize, no matter whether it is genetically modified or not, cannot by itself spread out from the land on which it is cultivated. There are no plants native to Germany with which the maize plants can successfully cross-breed. Furthermore, the corn is not able to survive a German winter.

However, agricultural ecologist Rdiger Gra from the University of Kassel gives some food for thought: "If like this year we have a very mild winter, or the maize becomes ploughed into the earth, the plants could germinate afresh."

All plants have an effect on their environment and the soil, and here genetically modified maize is neither an exception nor a larger danger, adds Gra. "Maize pollen, which is blown into streams and rivers, does however serve as basic nourishment for smaller animals." All possible impacts of the GM corn have not yet been conclusively examined.

Possibly. In Germany about 2.5 million hectares of maize will be cultivated, that covers about a fifth of the country's total arable land. Europe-wide there are more than 500 maize varieties and hybrids. So, is it possible to prevent genetically modified maize from mixing with other maize types?

Wild pigs, bees and other animals could have a hand in mixing up maize varieties, says plant researcher Rdiger Gra, who believes, however, that the flight of pollen is the biggest contamination risk: "In areas of law relating to genetic modification technology there is talk about different minimum distances between the fields. At the same time, no-one can seriously answer how much of a gap is safe." Whether maize pollen can travel for 100 or 1000 meters, the agricultural scientist says, depends among other things on the wind strength and air temperature - and has nothing to do with the type of maize.

View original post here:
Five fears about GM corn

Recommendation and review posted by Bethany Smith

PUBLIC RELEASE DATE:

14-Apr-2014

Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center

STANFORD, Calif. As many as 10 percent of women with a personal or family history of breast or ovarian cancer have at least one genetic mutation that, if known, would prompt their doctors to recommend changes in their care, according to a new study by researchers at the Stanford University School of Medicine.

The women in the study did not have mutations in BRCA1 or BRCA2 (mutations in these genes are strongly associated with hereditary breast and ovarian cancer), but they did have mutations in other cancer-associated genes.

The study was conducted using what's known as a multiple-gene panel to quickly and cheaply sequence just a few possible genetic culprits selected by researchers based on what is known about a disease. Although such panels are becoming widely clinically available, it's not been clear whether their use can help patients or affect medical recommendations.

"Although whole-genome sequencing can clearly be useful under the right conditions, it may be premature to consider doing on everyone," said James Ford, MD, who directs Stanford's Clinical Cancer Genetics Program. "Gene panels offer a middle ground between sequencing just a single gene like BRCA1 that we are certain is involved in disease risk, and sequencing every gene in the genome. It's a focused approach that should allow us to capture the most relevant information."

Ford, an associate professor of medicine and of genetics, is the senior author of the study, which will be published April 14 in the Journal of Clinical Oncology. Allison Kurian, MD, assistant professor of medicine and of health research and policy, and associate director of the Clinical Cancer Genetics Program, is the study's lead author.

Ford was a co-author on a recent paper in the in The Journal of the American Medical Association that highlighted the challenges and opportunities of making whole-genome sequencing clinically available for seemingly healthy people. Although that study showed that whole-genome sequencing can be potentially life-saving, the challenges involved in sequencing the billions of nucleotides that make up all of a person's DNA, and then translating the results into clinical care recommendations, is significant.

"This study indicates that using gene panels to screen for potentially harmful variants can be clinically useful in certain groups of patients," said Kurian. "It also shows that patients, some of whom had given blood samples for research as many as 10 years earlier, are willing and interested to receive this type of follow-up information and to incorporate it into their health care plans."

More:
Gene panels may be useful, cheaper alternative to whole-genome sequencing, study finds

Recommendation and review posted by Bethany Smith

Genetics and law of probability when order specified and not specified
Question: What is the probability of a woman who will have 5 children giving birth to four girls and 1 boy in that order? Answer: The probability of giving b...

By: GeneticsLessons

Read the original here:
Genetics and law of probability when order specified and not specified - Video

Recommendation and review posted by Bethany Smith

Wellcome Trust Centre for Human Genetics
The WTCHG is a research institute of the Nuffield Department of Medicine at the University of Oxford, funded by the University, the Wellcome Trust and numero...

By: OxfordNDM

Read more here:
Wellcome Trust Centre for Human Genetics - Video

Recommendation and review posted by Bethany Smith

FTB Monster with Bjorn Santhil - Episode 17: Creeperhunt and Advanced Genetics
Welcome in Episode 17, where we need to hunt down more creepers!!! * Watch more FTB with Bjorn - http://www.youtube.com/user/Blivius92...

By: Blivius 92

View post:
FTB Monster with Bjorn & Santhil - Episode 17: Creeperhunt and Advanced Genetics - Video

Recommendation and review posted by Bethany Smith

Keyword Genetics Review - Should You Buy Keyword Genetics?
Keyword Genetics Review - CLICK HERE: http://www.WorkingAtHome4U.com/yt002.html Discover the the whole story and check out your options before buying! Can Ke...

By: Steve Rich

Here is the original post:
Keyword Genetics Review - Should You Buy Keyword Genetics? - Video

Recommendation and review posted by Bethany Smith

Genetics: The Roots of Life
A documentary video that proves genetics the roots of all living beings.

By: CryptoPPARs

View original post here:
Genetics: The Roots of Life - Video

Recommendation and review posted by Bethany Smith

Let #39;s play Mace Griffin: Bounty Hunter - 14 - Genetics Lab
I jinxed it... SA Thread http://forums.somethingawful.com/showthread.php?threadid=3592320.

By: Tin Tim

More here:
Let's play Mace Griffin: Bounty Hunter - 14 - Genetics Lab - Video

Recommendation and review posted by Bethany Smith

Human Mutation Lora Bean, Madhuri Hegde, and Stuart Tinker
This video describes the two components of Emory Genetics Laboratory #39;s (EGL) in-house developed data management system. The first is a highly-curated variant...

By: Emory Genetics Laboratory

Read more:
Human Mutation Lora Bean, Madhuri Hegde, and Stuart Tinker - Video

Recommendation and review posted by Bethany Smith

Advanced Genetics mod review have any mob #39;s ability in minecraft
today i review the advanced genetics mod review become any mob in minecraft! sorry if its boring.

By: theepicgamer1447

Read the original post:
Advanced Genetics mod review have any mob's ability in minecraft - Video

Recommendation and review posted by Bethany Smith

Timothytrespas-Genetics, chromaphores=nanoelectronics! Targeted Individual science.
Timothytrespas- Genetics,Chromaphores=organic, biological, ultra fast Nano-electronics. Targeted Individual science update: Timothytrespas, a targeted indivi...

By: Timothytrespas

Go here to read the rest:
Timothytrespas-Genetics, chromaphores=nanoelectronics! Targeted Individual science. - Video

Recommendation and review posted by Bethany Smith

Gene Therapy PSA Dan Lesser Period 2
Ms. Mattairs PSA Bioethics PSA By Dan Lesser Period:2 I do not own this song or any footage.

By: Dan Lesser

Excerpt from:
Gene Therapy PSA Dan Lesser Period 2 - Video

Recommendation and review posted by Bethany Smith

T he International Cellular Medicine Society (ICMS) is an international non-profit dedicated to patient safety through strict evaluation of protocols and rigorous oversight of clinics and facilities engaged in the translation of point-of-care cell-based treatments.As a Professional Medical Association, the ICMS represents Physiciansand Researchersfrom over 35 countries who share a mission to provide Scientifically Credible and Medically Appropriate Treatments to Informed Patients.Join the ICMS.

The ICMS Works Tirelessly for the Clincial Translation of Field of Cell-Based Point-of-Care Treatments through:

Comprehensive Medical Standards and Best Practice Guidelines for Cell Based Medicine,

Strict Evaluation and Rigerous Oversight of Stem Cell Clinics and Facilities through aGlobal Accreditation Process,

Physician Education through daily updates on the latest Research on Stem Cells, the monthly Currents In Stem Cell Medicine and the annual International Congress for Regenerative and Stem Cell Medicine.

Join the ICMSto receive the latest news and research from cell-based medicne, including the bi-monthly publication, Currents in Stem Cell Medicine.

Read the original:
Stem Cells | ICMS -- Advancing Stem Cell Treatments, Stem ...

Recommendation and review posted by simmons